CK2/PIM1-IN-1
Modify Date: 2024-01-09 23:32:53
CK2/PIM1-IN-1 structure
|
Common Name | CK2/PIM1-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 292640-28-9 | Molecular Weight | 331.37 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C15H9NO4S2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CK2/PIM1-IN-1CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders[1]. |
| Name | CK2/PIM1-IN-1 |
|---|
| Description | CK2/PIM1-IN-1 is an inhibitor of CK2 and PIM1, with IC50s of 3.787 μM and 4.327 μM for CK2 and PIM1, respectively. CK2/PIM1-IN-1 is developed for the research of proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, vascular disorders, pathogenic infections and certain immunological disorders[1]. |
|---|---|
| Related Catalog | |
| Target |
CK2:3.787 μM (IC50) PIM1:4.327 μM (IC50) |
| In Vitro | CK2/PIM1-IN-1 a PIM kinases and CK2 inhibitor extracted from patent WO2010148351A1, Compound Example 64[1]. |
| References |
[1]. Mustapha Haddach, et al. Rhodanines and related heterocycles as kinase inhibitors. WO2010148351A1. |
| Molecular Formula | C15H9NO4S2 |
|---|---|
| Molecular Weight | 331.37 |